Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

317 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection.
Takenaka K, Fuji S, Matsukawa T, Uchida N, Kobayashi T, Tanaka M, Ara T, Ikegame K, Ozawa Y, Kanda Y, Sawa M, Maruyama Y, Fukuda T, Nakamae H, Kimura T, Ogata M, Seo S, Atsuta Y, Matsuo K, Nakasone H. Takenaka K, et al. Among authors: ara t. Ann Hematol. 2024 Jan;103(1):285-296. doi: 10.1007/s00277-023-05474-1. Epub 2023 Nov 10. Ann Hematol. 2024. PMID: 37947825
Reduced dose of MTX for GVHD prophylaxis promotes engraftment and decreases non-relapse mortality in umbilical cord blood transplantation.
Shiratori S, Ohigashi H, Takahashi S, Ara T, Goto H, Nakagawa M, Sugita J, Onozawa M, Kahata K, Endo T, Hashimoto D, Teshima T; North Japan Hematology Study Group (NJHSG). Shiratori S, et al. Among authors: ara t. Ann Hematol. 2020 Mar;99(3):591-598. doi: 10.1007/s00277-020-03937-3. Epub 2020 Feb 1. Ann Hematol. 2020. PMID: 32006152 Clinical Trial.
Peritransplant glucocorticoids redistribute donor T cells to the bone marrow and prevent relapse after haploidentical SCT.
Inoue T, Koyama M, Kaida K, Ikegame K, Ensbey KS, Samson L, Takahashi S, Zhang P, Minnie SA, Maruyama S, Ishii S, Daimon T, Fukuda T, Nakamae H, Ara T, Maruyama Y, Ishiyama K, Ichinohe T, Atsuta Y, Blazar BR, Furlan SN, Ogawa H, Hill GR. Inoue T, et al. Among authors: ara t. JCI Insight. 2021 Nov 22;6(22):e153551. doi: 10.1172/jci.insight.153551. JCI Insight. 2021. PMID: 34637399 Free PMC article.
Characterization of myeloid neoplasms following allogeneic hematopoietic cell transplantation.
Kuno M, Yamasaki S, Fujii N, Ishida Y, Fukuda T, Kataoka K, Uchida N, Katayama Y, Sato M, Onai D, Miyamoto T, Ota S, Yoshioka S, Ara T, Hangaishi A, Hashii Y, Onizuka M, Ichinohe T, Atsuta Y, Inamoto Y; on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group. Kuno M, et al. Among authors: ara t. Am J Hematol. 2022 Feb 1;97(2):185-193. doi: 10.1002/ajh.26401. Epub 2021 Nov 16. Am J Hematol. 2022. PMID: 34738245 Free article.
Antithymocyte Globulin Potentially Could Overcome an Adverse Effect of Acute Graft-versus-Host Disease in Matched-Related Peripheral Blood Stem Cell Transplantation.
Miyao K, Kuwatsuka Y, Murata M, Nagafuji K, Teshima T, Takeuchi Y, Shiratori S, Najima Y, Uchida N, Tanaka M, Sawa M, Ota S, Fukuda T, Ozawa Y, Kako S, Kawakita T, Ara T, Tanaka J, Kanda Y, Atsuta Y, Kanda J, Terakura S; GVHD Working Group and Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy. Miyao K, et al. Among authors: ara t. Transplant Cell Ther. 2022 Mar;28(3):153.e1-153.e11. doi: 10.1016/j.jtct.2021.12.009. Epub 2021 Dec 22. Transplant Cell Ther. 2022. PMID: 34954151 Free article.
Risk and Predictive Factors for Candidemia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working Group.
Kimura SI, Kameda K, Harada K, Saburi M, Okinaka K, Shinohara A, Uchida N, Nishijima A, Ozawa Y, Tanaka M, Kuriyama T, Katayama Y, Sawa M, Ikegame K, Kawakita T, Kanda Y, Nakamae H, Ara T, Kimura T, Sato A, Fukuda T, Atsuta Y, Nakasone H. Kimura SI, et al. Among authors: ara t. Transplant Cell Ther. 2022 Apr;28(4):209.e1-209.e9. doi: 10.1016/j.jtct.2021.12.020. Epub 2022 Jan 5. Transplant Cell Ther. 2022. PMID: 34995815 Free article.
Disease-specific impact of anti-thymocyte globulin in allogeneic hematopoietic cell transplantation: a nationwide retrospective study on behalf of the JSTCT, transplant complications working group.
Fuji S, Hirakawa T, Takano K, Doki N, Sawa M, Kanda Y, Uchida N, Ara T, Miyamoto T, Eto T, Matsuoka KI, Kawakita T, Ozawa Y, Katayama Y, Onizuka M, Fukuda T, Atsuta Y, Nakasone H. Fuji S, et al. Among authors: ara t. Bone Marrow Transplant. 2022 Mar;57(3):479-486. doi: 10.1038/s41409-022-01569-x. Epub 2022 Jan 17. Bone Marrow Transplant. 2022. PMID: 35039621
Deletion of Y chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors.
Tamaki M, Kameda K, Kimura SI, Harada N, Uchida N, Doki N, Tanaka M, Ikegame K, Sawa M, Katayama Y, Miyakoshi S, Ara T, Kanda J, Onizuka M, Fukuda T, Atsuta Y, Kanda Y, Yakushijin K, Nakasone H. Tamaki M, et al. Among authors: ara t. Blood Adv. 2022 Mar 22;6(6):1895-1903. doi: 10.1182/bloodadvances.2021006456. Blood Adv. 2022. PMID: 35108728 Free PMC article.
317 results